Skip to main content

Drugs

Ausgabe 16/2019

Inhalt (11 Artikel)

Current Opinion

As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?

Christian Domingo, Jordi Rello, Ana Sogo

Correction

Correction to: As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?

Christian Domingo, Jordi Rello, Ana Sogo

Review Article

Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects

Chiara Crotti, Elena Agape, Andrea Becciolini, Martina Biggioggero, Ennio Giulio Favalli

Open Access Review Article

Benefit:Risk Profile of Budesonide in Obstructive Airways Disease

Donald P. Tashkin, Brian Lipworth, Ralph Brattsand

Adis Drug Evaluation

Lanadelumab: A Review in Hereditary Angioedema

Yahiya Y. Syed

Adis Drug Evaluation

Stiripentol: A Review in Dravet Syndrome

James E. Frampton

AdisInsight Report

Pretomanid: First Approval

Susan J. Keam

Open Access AdisInsight Report

Pexidartinib: First Approval

Yvette N. Lamb

AdisInsight Report

Darolutamide: First Approval

Anthony Markham, Sean Duggan

AdisInsight Report

Upadacitinib: First Approval

Sean Duggan, Susan J. Keam

Open Access Correction

Correction to: Polatuzumab Vedotin: First Global Approval

Emma D. Deeks

Aktuelle Ausgaben